On Mar 2 – 5, 2021, TIDES Asia made its debut as a Virtual Scientific Forum, with a series of live and recorded webinars, presented by industry experts, screened across the week.
Over 700 industry professionals registered to watch the webinars online over the course of the week, which explored topics across discovery, CMC and development of peptide, oligonucleotide, mRNA and genome edited therapeutics. The audience now continues to grow as the sessions remain available to stream on-demand for free on the TIDES Content Hub.
In this report, we review the hottest webinars at the TIDES Asia Virtual Scientific Forum 2021, including the latest work in antisense technology, mRNA-based vaccines, novel, modular GalNAc access and peptide drug discovery and development.
1. How Antisense Drugs Work: Molecular Mechanisms of Cellular Pharmacokinetics, Pharmacodynamis and Toxicity
In this keynote presentation, Stan Crooke, Executive Chairman of Ionis Pharmaceuticals explained the principles behind the recent and long-awaited successes in antisense technology.
2. N-Lorem a New Charitable Foundation: Creating Individualized Treatments for Patients with Ultra-Rare Diseases using Antisense
In a follow-up, Stan Crooke revealed how he created a foundation to create individualized treatments for patients with ultra-rare diseases using the technology developed at Ionis Pharmaceuticals.
3. LGC’s Development of a Novel, Modular, GalNAc Access, and Conjugation Strategies for Nucleic Acid Medicines
This on-demand presentation explores how LGC Nucleic Acid Chemistry (NAC) group enables a novel, modular access to a proprietary GalNAc ligand system without affecting the phosphate backbone of the corresponding oligonucleotide.
4. A Strategic Vision for Therapeutic Development: The PeptiDream Story
Patrick Reid, President, CEO and Chairman of the Board at PeptiDream Inc., provided an overview of the strategic vision and business philosophy that has guided PeptiDream’s evolution into one of the leading peptide drug discovery and development companies in the field.
5. RNA Therapeutics: Importance of Nucleotide Sequence and Modifications on the Mechanism of Action
In a keynote presentation, Dr. Sudhir Agrawal, Founder & President at Arnay Sciences explained the fundamentals of producing RNA therapeutics.
6. Usage of an mRNA Platform Technology for “Light Speed” Development of a Vaccine against SARS-CoV-2
As an update to his popular presentation at TIDES Europe, Andreas Kuhn at BioNTech RNA Pharmaceuticals GmbH revealed the recent development milestones of a vaccine against SARS-CoV-2.